Variables | Incidence of TBC | COR (95% CI) | AOR (95% CI) | P-Value | |
Yes | No | ||||
Age 15 - 24 25 - 34 35 - 44 ≥45 |
8 (12.1) 46 (19.6) 33 (24.1) 19 (32.8) |
58 (87.9) 189 (80.4) 104 (75.9) 39 (67.2) |
1 1.76 (0.78, 3.95) 2.30 (0.99, 5.31) 3.53 (1.41, 8.87 |
- |
|
Disclosure status Disclosed Not disclosed |
106 (21.5) 0 (0.0) |
386 (78.5) 4 (100) |
2.51 (1.27-4.98) 1 | - |
|
Family size ≤2 3 - 4 ≥5 |
19 (15.0) 55 (24.9) 32 (21.6) |
108 (85.0) 166 (75.1) 116 (78.4) |
1 1.88 (1.06, 3.35) 1.57 (0.84, 2.93) |
1 2.26 (1.14 - 4.50) 1.76 (0.83 - 3.69) |
0.02 0.14 |
Cigarette smoking Yes No |
20 (46.5) 86 (19.0) |
23 (53.6) 367 (81.0) |
3.71 (1.95, 7.06) 1 |
2.82 (1.27 - 6.27) 1 |
0.011 |
ART intervention Pre-ART HAART |
16 (11.7) 90 (25.1) |
121 (88.3) 269 (74.9) |
1 2.53 (1.43, 4.49) | - |
|
Type of initial regimen 1a 1b 1c 1d 1e + 1f |
19 (11.7) 19 (29.7) 5 (8.3) 13 (23.6) 34 (24.3) |
121 (88.3) 45 (70.3) 21 (52.5) 55 (91.7) 42 (76.4) |
1.32 (0.68, 2.55) 2.82 (1.36, 5.85) 0.28 (0.11, 0.76) 0.96 (0.46, 2.00) 1 | - |
|
Past TB treatment history Yes No |
22 (32.4) 84 (19.6) |
46 (67.6) 344 (80.4) |
1.96 (1.12, 3.43) 1 | - |
|
WHO clinical stage I II III IV |
7 (6.1) 6 (3.5) 76 (43.9) 17 (44.7) |
108 (93.9) 164 (96.5) 97 (56.1) 21 (55.3) |
1 0.56 (0.18, 1.72) 12.0 (5.31, 27.5) 12.5 (4.61, 33.8) |
1 0.33 (0.06 - 1.86) 20.26 (7.09 - 57.6) 22.9 (6.91 - 76.4) |
0.21 <0.001 <0.001 |
CD4 count <50 50 - 100 101 - 200 200 |
20 (57.1) 23 (39.7) 38 (29.9) 25 (9.1) |
15 (42.5) 35 (60.3) 89 (70.1) 251 (90.9) |
13.4 (6.10, 29.4) 6.59 (3.38, 12.8) 4.28 (2.44, 7.50) 1 |
|
|
Hemoglobin <10 ≥10 |
24 (48) 82 (18.4) |
26 (52) 364 (81.6) |
1 3.46 (1.30, 9.18) |
1 2.56 (1.22 - 5.33) |
0.012 |